You are here: Home » International » News » Others
Business Standard

WHO gives emergency use listing to Moderna's coronavirus vaccine

Many countries without their own advanced medical regulatory and assessment offices rely on the WHO listing to decide whether to use vaccines

Topics
Coronavirus | Coronavirus Tests | Coronavirus Vaccine

AP | PTI  |  Geneva 

Moderna

The World Health Organisation has given the go-ahead for emergency use of Moderna's COVID-19 vaccine.

The mRNA vaccine from the US manufacturer joins vaccines from AstraZeneca, Pfizer-BioNTech and Johnson & Johnson in receiving the WHO's emergency use listing.

Similar approvals for China's Sinopharm and Sinovac vaccines are expected in the coming days and weeks, WHO has said.

The greenlight for Moderna's vaccine, announced late Friday, took many months because of delays that WHO faced in getting data from the manufacturer.

Many countries without their own advanced medical regulatory and assessment offices rely on the WHO listing to decide whether to use vaccines. UN children's agency UNICEF also uses the listing to deploy vaccines in an emergency like the pandemic.

The announcement, however, wasn't likely to have an immediate impact on supplies of Moderna's vaccine for the developing world. The company struck supply agreements with many rich countries, which will have already received millions of doses.

In a statement Friday, CEO Stephane Bancel said Moderna was actively participating in discussions with multilateral organisations, such as COVAX, to help protect populations around the world.

He was referring to a UN-backed programme to ship COVID-19 vaccines to many low- and middle-income countries, based on need.

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Sat, May 01 2021. 17:35 IST
RECOMMENDED FOR YOU
.